The Panbio® Dengue IgM Capture ELISA is used to detect IgM antibodies to dengue antigen in serum as an aid to clinical laboratory diagnosis of patients with clinical symptoms consistent with dengue fever. The Panbio® Dengue IgM Capture ELISA should be used in conjunction with other dengue serology.
Overview
Documentation
Order & Support Info
Benefits
Flexible: Use in conjunction with Dengue IgG Capture ELISA to differentiate primary and secondary infection
Easy to use: The test uses a single dilution of serum, rather than a series of dilutions required for HAI assays
Cost effective: Break-apart wells and ready-to-use colorcoded reagents are compatible with standard microplate technology
Rapid: The total incubation time for the Dengue IgM assay is 2 hr 10 min
Specifications
255 characterzed sera were tested on the Panbio Dengue IgM Capture ELISA as part of an in-house study. The sera included 83 endemic seronegative samples, 57 samples from patients with primary dengue infection, and 115 samples from patients with secondary dengue infection. The Panbio Dengue IgM Capture ELISA results were compared to the dengue status of the sera to determine sensitivity, specificity, and agreement of the assay relative to the dengue serological status.
Sensitivity: 94.7% for primary dengue
Specificity: *
Specifications:
Serological sensitivity: IgM
Primary dengueb: 64/115 (55.7%)
Serological specificity: IgM
Negatives: 83/83 (*)
a This data has been extracted from the Dengue IgM Capture ELISA Intructions for Use
b Samples positive for secondary dengue infection by HAI
c The use of the Panbio® Dengue IgG Capture ELISA (E-DEN02G) is recommended when secondary dengue is suspected
SKU
no sku
長久以來,澳大利亞Panbio公司在臨床實驗室應用的創新性的檢測產品開發方面一直保持的良好記錄。 Panbio一直在登革熱(Dengue fever)、羅斯河熱(Ross river fever)的診斷試劑產品方面保持著*的市場地位。公司的西尼羅河腦炎(West Nile encephalopalitis)診斷試劑在獲得美國FDA注冊。 Panbio登革產品擁有zui廣的產品系列,有著zui廣的應用。